个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

The Treatment of Diffuse Large B-Cell Lymphoma (Triple Expression) Involving the Breast, Spleen, and Bone in a Male Patient with Viral Hepatitis B: A Rare Case Report

| 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Zhou Weiling[1] * ; Gao Qian[1] ; Wang Lianjing[2] ; Li Weijing[2] ; He Cuiying[2] ; Li Yanting[3] ; Feng Lei[1] ; Liu Wei[2] ; Liu Lihong[2,*1] ; Wang Yuan[1,*2] ;
机构： [1]Department of Endocrine and Metabolic Diseases, The Fourth Hospital of Hebei Medical University, Shijiazhuang, HeBei Province, 050000, People's Republic of China. [2]Department of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, HeBei Province, 050000, People's Republic of China. [3]Department of Glandular Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, HeBei Province, 050000, People's Republic of China.
出处：
DOI： 10.2147/CMAR.S427217
ISSN：

关键词： breast viral hepatitis B diffuse large B-cell lymphoma triple expression autologous stem cell transplantation

摘要：
Diffuse large B-cell lymphoma (DLBCL) involving the breast, spleen, and bone in a male patient with hepatitis B virus (HBV) infection is extremely rare in clinical practice.We report a case of DLBCL involving the breast, spleen, and bone (triple expression of Bcl-2+, Bcl-6+, and 70% positive C-mcy) in a male patient with HBV admitted to our hospital. The patient was treated with EPOCH×4, lenalidomide+EPOCH×2 chemotherapy, intermittent methotrexate intrathecal injections to prevent central invasion, and autologous stem cell transplantation (ASCT). The patient is currently in complete remission, and the follow-up time was 43 months.A patient with DLBCL involving the breast, spleen, and bone can be treated with a combination of multiple regimens. If the patient's economic conditions permit it, ASCT can be considered.© 2023 Zhou et al.

基金：
This research was supported by the Department of Science and Technology of Hebei Province of China (No. 20221232, No. 20230803 and No. 20221266).
语种：
外文
WOS：
PubmedID：
中科院分区：
出版当年[2023]版：
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2025]版：
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区：
出版当年[2023]版：
Q3 ONCOLOGY
最新[2023]版：
Q3 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者：
第一作者机构： [1]Department of Endocrine and Metabolic Diseases, The Fourth Hospital of Hebei Medical University, Shijiazhuang, HeBei Province, 050000, People's Republic of China.
通讯作者：
通讯机构： [1]Department of Endocrine and Metabolic Diseases, The Fourth Hospital of Hebei Medical University, Shijiazhuang, HeBei Province, 050000, People's Republic of China. [2]Department of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, HeBei Province, 050000, People's Republic of China. [*1]Department of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, HeBei Province, 050000,People’s Republic of China [*2]Department of Endocrine and Metabolic Diseases, The Fourth Hospital of Hebei Medical University, Shijiazhuang, HeBei Province, 050000, People’s Republic of China
推荐引用方式(GB/T 7714)：
Zhou Weiling,Gao Qian,Wang Lianjing,et al.The Treatment of Diffuse Large B-Cell Lymphoma (Triple Expression) Involving the Breast, Spleen, and Bone in a Male Patient with Viral Hepatitis B: A Rare Case Report[J].CANCER MANAGEMENT AND RESEARCH.2023,15:983-988.doi:10.2147/CMAR.S427217.
APA：
Zhou Weiling,Gao Qian,Wang Lianjing,Li Weijing,He Cuiying...&Wang Yuan.(2023).The Treatment of Diffuse Large B-Cell Lymphoma (Triple Expression) Involving the Breast, Spleen, and Bone in a Male Patient with Viral Hepatitis B: A Rare Case Report.CANCER MANAGEMENT AND RESEARCH,15,
MLA：
Zhou Weiling,et al."The Treatment of Diffuse Large B-Cell Lymphoma (Triple Expression) Involving the Breast, Spleen, and Bone in a Male Patient with Viral Hepatitis B: A Rare Case Report".CANCER MANAGEMENT AND RESEARCH 15.(2023):983-988

相关文献

[1]Genomic Landscape of Primary Breast Lymphoma Diffuse Large B-Cell Lymphoma (PB-DLBCL) [2]Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma [3]Influence of Hyperglycemia on the Prognosis of Patients with Diffuse Large B-Cell Lymphoma [4]Insulin Resistance and the Prognosis in Diffuse Large B-cell Lymphoma [5]Baseline 18F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma [6]Primary diffuse large B-cell lymphoma of the breast: A retrospective study of outcomes and insulin resistance [7]Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure [8]Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL). [9]Efficacy and safety of orelabrutinib in diffuse large B-cell lymphoma: A real-world analysis [10]Primary pancreatic mucosa-associated lymphoid tissue lymphoma transformed into diffuse large B-cell lymphoma: a case report and literature review.

资源点击量：39770 今日访问量：0 总访问量：1333 更新日期：2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持：重庆聚合科技有限公司 地址：河北省石家庄市健康路12号